Patent ID: 11866496
Assignee: GENENTECH, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 13:
14. The immunoconjugate of claim 10, wherein the immunoconjugate comprises the formula:, wherein R17 is a divalent radical selected from the group consisting of (CH2)r, C3-C8 carbocyclyl, O—(CH2)r, arylene, (CH2)r-arylene, -arylene-(CH2)r—, (CH2)r—(C3-C8 carbocyclyl), (C3-C8 carbocyclyl)-(CH2)r, C3-C8 heterocyclyl, (CH2)r—(C3-C8 heterocyclyl), —(C3-C8 heterocyclyl)-(CH2)r—, —(CH2)rC(O)NRb(CH2)r—, —(CH2CH2O)r—, —(CH2CH2O)r—CH2—, —(CH2)rC(O)NRb(CH2CH2O)r—, —(CH2)rC(O)NRb(CH2CH2O)r—CH2—, —(CH2CH2O)rC(O)NRb(CH2CH2O)r—, —(CH2CH2O)rC(O)NRb(CH2CH2O)r—CH2—, and —(CH2CH2O)rC(O)NRb(CH2)r—;
wherein Rb is H, C1-C6 alkyl, phenyl, or benzyl; and r is independently an integer ranging from 1 to 10.